nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrosine—TH—peripheral nervous system neoplasm	0.568	1	CbGaD
Metyrosine—L-Tyrosine—Melphalan—peripheral nervous system neoplasm	0.173	0.5	CrCrCtD
Metyrosine—Ibuprofen—Melphalan—peripheral nervous system neoplasm	0.173	0.5	CrCrCtD
Metyrosine—TH—vagus nerve—peripheral nervous system neoplasm	0.0115	0.282	CbGeAlD
Metyrosine—TH—cranial nerve—peripheral nervous system neoplasm	0.00874	0.215	CbGeAlD
Metyrosine—TH—pons—peripheral nervous system neoplasm	0.00864	0.213	CbGeAlD
Metyrosine—TH—Parkinsons Disease Pathway—PINK1—peripheral nervous system neoplasm	0.0046	0.431	CbGpPWpGaD
Metyrosine—TH—nerve—peripheral nervous system neoplasm	0.00448	0.11	CbGeAlD
Metyrosine—TH—ganglion—peripheral nervous system neoplasm	0.00442	0.109	CbGeAlD
Metyrosine—TH—brainstem—peripheral nervous system neoplasm	0.00192	0.0473	CbGeAlD
Metyrosine—L-Tyrosine—TH—peripheral nervous system neoplasm	0.00174	0.831	CrCbGaD
Metyrosine—TH—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.00117	0.11	CbGpPWpGaD
Metyrosine—TH—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00113	0.106	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—NF1—peripheral nervous system neoplasm	0.000976	0.0915	CbGpPWpGaD
Metyrosine—TH—cerebellum—peripheral nervous system neoplasm	0.000948	0.0233	CbGeAlD
Metyrosine—Thrombocytosis—Tretinoin—peripheral nervous system neoplasm	0.000928	0.0282	CcSEcCtD
Metyrosine—Thrombocytosis—Isotretinoin—peripheral nervous system neoplasm	0.000928	0.0282	CcSEcCtD
Metyrosine—Thrombocytosis—Alitretinoin—peripheral nervous system neoplasm	0.000703	0.0213	CcSEcCtD
Metyrosine—Swelling—Isotretinoin—peripheral nervous system neoplasm	0.000475	0.0144	CcSEcCtD
Metyrosine—Swelling—Tretinoin—peripheral nervous system neoplasm	0.000475	0.0144	CcSEcCtD
Metyrosine—Nasal congestion—Tretinoin—peripheral nervous system neoplasm	0.00046	0.0139	CcSEcCtD
Metyrosine—Nasal congestion—Isotretinoin—peripheral nervous system neoplasm	0.00046	0.0139	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Topotecan—peripheral nervous system neoplasm	0.00038	0.0115	CcSEcCtD
Metyrosine—TH—Parkinsons Disease Pathway—CASP3—peripheral nervous system neoplasm	0.000374	0.0351	CbGpPWpGaD
Metyrosine—Swelling—Alitretinoin—peripheral nervous system neoplasm	0.00036	0.0109	CcSEcCtD
Metyrosine—Nasal congestion—Alitretinoin—peripheral nervous system neoplasm	0.000348	0.0106	CcSEcCtD
Metyrosine—Dysuria—Isotretinoin—peripheral nervous system neoplasm	0.000338	0.0103	CcSEcCtD
Metyrosine—Dysuria—Tretinoin—peripheral nervous system neoplasm	0.000338	0.0103	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000324	0.0304	CbGpPWpGaD
Metyrosine—Aspartate aminotransferase increased—Dactinomycin—peripheral nervous system neoplasm	0.000308	0.00935	CcSEcCtD
Metyrosine—Haematuria—Tretinoin—peripheral nervous system neoplasm	0.000308	0.00934	CcSEcCtD
Metyrosine—Haematuria—Isotretinoin—peripheral nervous system neoplasm	0.000308	0.00934	CcSEcCtD
Metyrosine—Thrombocytosis—Epirubicin—peripheral nervous system neoplasm	0.000308	0.00933	CcSEcCtD
Metyrosine—Nasal congestion—Cisplatin—peripheral nervous system neoplasm	0.000297	0.00901	CcSEcCtD
Metyrosine—Hallucination—Tretinoin—peripheral nervous system neoplasm	0.000288	0.00875	CcSEcCtD
Metyrosine—Hallucination—Isotretinoin—peripheral nervous system neoplasm	0.000288	0.00875	CcSEcCtD
Metyrosine—Oedema peripheral—Tretinoin—peripheral nervous system neoplasm	0.000285	0.00866	CcSEcCtD
Metyrosine—Oedema peripheral—Isotretinoin—peripheral nervous system neoplasm	0.000285	0.00866	CcSEcCtD
Metyrosine—Thrombocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.00864	CcSEcCtD
Metyrosine—Swelling—Etoposide—peripheral nervous system neoplasm	0.000281	0.00852	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Vincristine—peripheral nervous system neoplasm	0.000275	0.00836	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000264	0.0248	CbGpPWpGaD
Metyrosine—Dysuria—Alitretinoin—peripheral nervous system neoplasm	0.000256	0.00778	CcSEcCtD
Metyrosine—Dysuria—Vincristine—peripheral nervous system neoplasm	0.000247	0.0075	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Cisplatin—peripheral nervous system neoplasm	0.000243	0.00739	CcSEcCtD
Metyrosine—Erectile dysfunction—Vincristine—peripheral nervous system neoplasm	0.000243	0.00739	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000242	0.0227	CbGpPWpGaD
Metyrosine—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.000236	0.00717	CcSEcCtD
Metyrosine—Tremor—Tretinoin—peripheral nervous system neoplasm	0.000236	0.00717	CcSEcCtD
Metyrosine—Anaemia—Topotecan—peripheral nervous system neoplasm	0.000235	0.00713	CcSEcCtD
Metyrosine—Haematuria—Alitretinoin—peripheral nervous system neoplasm	0.000233	0.00708	CcSEcCtD
Metyrosine—Anaemia—Tretinoin—peripheral nervous system neoplasm	0.000233	0.00707	CcSEcCtD
Metyrosine—Anaemia—Isotretinoin—peripheral nervous system neoplasm	0.000233	0.00707	CcSEcCtD
Metyrosine—Anaemia—Melphalan—peripheral nervous system neoplasm	0.00023	0.00698	CcSEcCtD
Metyrosine—Blood disorder—Epirubicin—peripheral nervous system neoplasm	0.000229	0.00695	CcSEcCtD
Metyrosine—Acetaminophen—ABCB1—peripheral nervous system neoplasm	0.000222	0.106	CrCbGaD
Metyrosine—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.00663	CcSEcCtD
Metyrosine—Oedema peripheral—Alitretinoin—peripheral nervous system neoplasm	0.000216	0.00656	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000216	0.0202	CbGpPWpGaD
Metyrosine—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.000214	0.00649	CcSEcCtD
Metyrosine—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.000214	0.00649	CcSEcCtD
Metyrosine—Blood disorder—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.00643	CcSEcCtD
Metyrosine—Hallucination—Vincristine—peripheral nervous system neoplasm	0.00021	0.00639	CcSEcCtD
Metyrosine—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.00021	0.00637	CcSEcCtD
Metyrosine—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.00021	0.00637	CcSEcCtD
Metyrosine—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.000208	0.0063	CcSEcCtD
Metyrosine—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.000208	0.0063	CcSEcCtD
Metyrosine—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.000203	0.00616	CcSEcCtD
Metyrosine—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000201	0.00611	CcSEcCtD
Metyrosine—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000201	0.00611	CcSEcCtD
Metyrosine—TH—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.0002	0.0187	CbGpPWpGaD
Metyrosine—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.000199	0.00604	CcSEcCtD
Metyrosine—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00019	0.00578	CcSEcCtD
Metyrosine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000186	0.00565	CcSEcCtD
Metyrosine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000186	0.00565	CcSEcCtD
Metyrosine—Salivary hypersecretion—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00564	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.000179	0.0168	CbGpPWpGaD
Metyrosine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000179	0.00543	CcSEcCtD
Metyrosine—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000179	0.00543	CcSEcCtD
Metyrosine—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000177	0.00538	CcSEcCtD
Metyrosine—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000177	0.00538	CcSEcCtD
Metyrosine—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.000177	0.00536	CcSEcCtD
Metyrosine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000175	0.00531	CcSEcCtD
Metyrosine—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00522	CcSEcCtD
Metyrosine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000171	0.00519	CcSEcCtD
Metyrosine—Anaemia—Vincristine—peripheral nervous system neoplasm	0.00017	0.00517	CcSEcCtD
Metyrosine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00017	0.00515	CcSEcCtD
Metyrosine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00017	0.00515	CcSEcCtD
Metyrosine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00017	0.00515	CcSEcCtD
Metyrosine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000168	0.00511	CcSEcCtD
Metyrosine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000168	0.00511	CcSEcCtD
Metyrosine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000165	0.005	CcSEcCtD
Metyrosine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000165	0.005	CcSEcCtD
Metyrosine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000164	0.00498	CcSEcCtD
Metyrosine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000163	0.00496	CcSEcCtD
Metyrosine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000163	0.00496	CcSEcCtD
Metyrosine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000163	0.00494	CcSEcCtD
Metyrosine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000163	0.00494	CcSEcCtD
Metyrosine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000162	0.00492	CcSEcCtD
Metyrosine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000161	0.0049	CcSEcCtD
Metyrosine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000159	0.00483	CcSEcCtD
Metyrosine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000157	0.00477	CcSEcCtD
Metyrosine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000153	0.00464	CcSEcCtD
Metyrosine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.00463	CcSEcCtD
Metyrosine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000153	0.00463	CcSEcCtD
Metyrosine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000152	0.0046	CcSEcCtD
Metyrosine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000152	0.0046	CcSEcCtD
Metyrosine—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.00015	0.00457	CcSEcCtD
Metyrosine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00015	0.00454	CcSEcCtD
Metyrosine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000149	0.00452	CcSEcCtD
Metyrosine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000148	0.00448	CcSEcCtD
Metyrosine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000148	0.00448	CcSEcCtD
Metyrosine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000147	0.00447	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.000147	0.0138	CbGpPWpGaD
Metyrosine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000146	0.00442	CcSEcCtD
Metyrosine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000145	0.0044	CcSEcCtD
Metyrosine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000142	0.00431	CcSEcCtD
Metyrosine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000141	0.00428	CcSEcCtD
Metyrosine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000141	0.00427	CcSEcCtD
Metyrosine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000141	0.00427	CcSEcCtD
Metyrosine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000139	0.00422	CcSEcCtD
Metyrosine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000139	0.00421	CcSEcCtD
Metyrosine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000138	0.00419	CcSEcCtD
Metyrosine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000138	0.00418	CcSEcCtD
Metyrosine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000138	0.00417	CcSEcCtD
Metyrosine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000136	0.00413	CcSEcCtD
Metyrosine—TH—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000135	0.0127	CbGpPWpGaD
Metyrosine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000134	0.00408	CcSEcCtD
Metyrosine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000133	0.00404	CcSEcCtD
Metyrosine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000132	0.004	CcSEcCtD
Metyrosine—Ibuprofen—ABCB1—peripheral nervous system neoplasm	0.000132	0.063	CrCbGaD
Metyrosine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000131	0.00397	CcSEcCtD
Metyrosine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000131	0.00397	CcSEcCtD
Metyrosine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00013	0.00395	CcSEcCtD
Metyrosine—Headache—Topotecan—peripheral nervous system neoplasm	0.00013	0.00394	CcSEcCtD
Metyrosine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00013	0.00393	CcSEcCtD
Metyrosine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000129	0.00392	CcSEcCtD
Metyrosine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000129	0.00391	CcSEcCtD
Metyrosine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000129	0.00391	CcSEcCtD
Metyrosine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000129	0.0039	CcSEcCtD
Metyrosine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000128	0.00387	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000125	0.00379	CcSEcCtD
Metyrosine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000124	0.00376	CcSEcCtD
Metyrosine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.00376	CcSEcCtD
Metyrosine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000123	0.00374	CcSEcCtD
Metyrosine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000123	0.00374	CcSEcCtD
Metyrosine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000123	0.00373	CcSEcCtD
Metyrosine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000123	0.00373	CcSEcCtD
Metyrosine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000122	0.00371	CcSEcCtD
Metyrosine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000122	0.00371	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000121	0.0113	CbGpPWpGaD
Metyrosine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000121	0.00366	CcSEcCtD
Metyrosine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000121	0.00366	CcSEcCtD
Metyrosine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000119	0.00362	CcSEcCtD
Metyrosine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000119	0.00361	CcSEcCtD
Metyrosine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000119	0.00361	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.00351	CcSEcCtD
Metyrosine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000115	0.00349	CcSEcCtD
Metyrosine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000115	0.00349	CcSEcCtD
Metyrosine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000112	0.00341	CcSEcCtD
Metyrosine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000112	0.0034	CcSEcCtD
Metyrosine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000111	0.00336	CcSEcCtD
Metyrosine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.00334	CcSEcCtD
Metyrosine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00011	0.00332	CcSEcCtD
Metyrosine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000108	0.00327	CcSEcCtD
Metyrosine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000107	0.00325	CcSEcCtD
Metyrosine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000107	0.00324	CcSEcCtD
Metyrosine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000105	0.00319	CcSEcCtD
Metyrosine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00315	CcSEcCtD
Metyrosine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000103	0.00312	CcSEcCtD
Metyrosine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000102	0.0031	CcSEcCtD
Metyrosine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.0001	0.00304	CcSEcCtD
Metyrosine—Nausea—Dactinomycin—peripheral nervous system neoplasm	9.99e-05	0.00303	CcSEcCtD
Metyrosine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	9.96e-05	0.00302	CcSEcCtD
Metyrosine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	9.92e-05	0.00301	CcSEcCtD
Metyrosine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	9.79e-05	0.00297	CcSEcCtD
Metyrosine—Headache—Alitretinoin—peripheral nervous system neoplasm	9.77e-05	0.00297	CcSEcCtD
Metyrosine—TH—Metabolism—GNS—peripheral nervous system neoplasm	9.76e-05	0.00915	CbGpPWpGaD
Metyrosine—Urticaria—Etoposide—peripheral nervous system neoplasm	9.67e-05	0.00294	CcSEcCtD
Metyrosine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	9.62e-05	0.00292	CcSEcCtD
Metyrosine—Vomiting—Vincristine—peripheral nervous system neoplasm	9.56e-05	0.0029	CcSEcCtD
Metyrosine—Asthenia—Cisplatin—peripheral nervous system neoplasm	9.53e-05	0.00289	CcSEcCtD
Metyrosine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	9.46e-05	0.00287	CcSEcCtD
Metyrosine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	9.44e-05	0.00286	CcSEcCtD
Metyrosine—Headache—Vincristine—peripheral nervous system neoplasm	9.41e-05	0.00286	CcSEcCtD
Metyrosine—TH—Metabolism—NME1—peripheral nervous system neoplasm	9.36e-05	0.00877	CbGpPWpGaD
Metyrosine—Nausea—Alitretinoin—peripheral nervous system neoplasm	9.26e-05	0.00281	CcSEcCtD
Metyrosine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	9.09e-05	0.00276	CcSEcCtD
Metyrosine—TH—Metabolism—COX2—peripheral nervous system neoplasm	9.01e-05	0.00845	CbGpPWpGaD
Metyrosine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	8.97e-05	0.00272	CcSEcCtD
Metyrosine—Nausea—Vincristine—peripheral nervous system neoplasm	8.93e-05	0.00271	CcSEcCtD
Metyrosine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	8.76e-05	0.00266	CcSEcCtD
Metyrosine—Asthenia—Etoposide—peripheral nervous system neoplasm	8.73e-05	0.00265	CcSEcCtD
Metyrosine—Vomiting—Cisplatin—peripheral nervous system neoplasm	8.45e-05	0.00256	CcSEcCtD
Metyrosine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	8.33e-05	0.00253	CcSEcCtD
Metyrosine—Nausea—Cisplatin—peripheral nervous system neoplasm	7.89e-05	0.0024	CcSEcCtD
Metyrosine—Vomiting—Etoposide—peripheral nervous system neoplasm	7.74e-05	0.00235	CcSEcCtD
Metyrosine—Anaemia—Epirubicin—peripheral nervous system neoplasm	7.73e-05	0.00235	CcSEcCtD
Metyrosine—Headache—Etoposide—peripheral nervous system neoplasm	7.63e-05	0.00231	CcSEcCtD
Metyrosine—Nausea—Etoposide—peripheral nervous system neoplasm	7.23e-05	0.00219	CcSEcCtD
Metyrosine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	7.15e-05	0.00217	CcSEcCtD
Metyrosine—Anxiety—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.00215	CcSEcCtD
Metyrosine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	6.96e-05	0.00211	CcSEcCtD
Metyrosine—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.88e-05	0.00209	CcSEcCtD
Metyrosine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	6.68e-05	0.00203	CcSEcCtD
Metyrosine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.00199	CcSEcCtD
Metyrosine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.00195	CcSEcCtD
Metyrosine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	6.37e-05	0.00193	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	6.33e-05	0.00593	CbGpPWpGaD
Metyrosine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	6.18e-05	0.00188	CcSEcCtD
Metyrosine—Insomnia—Epirubicin—peripheral nervous system neoplasm	6.17e-05	0.00187	CcSEcCtD
Metyrosine—TH—Metabolism—ENO2—peripheral nervous system neoplasm	5.91e-05	0.00554	CbGpPWpGaD
Metyrosine—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.88e-05	0.00179	CcSEcCtD
Metyrosine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.71e-05	0.00173	CcSEcCtD
Metyrosine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.62e-05	0.00171	CcSEcCtD
Metyrosine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.58e-05	0.00169	CcSEcCtD
Metyrosine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.44e-05	0.00165	CcSEcCtD
Metyrosine—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.42e-05	0.00165	CcSEcCtD
Metyrosine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.39e-05	0.00164	CcSEcCtD
Metyrosine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.2e-05	0.00158	CcSEcCtD
Metyrosine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	5.16e-05	0.00157	CcSEcCtD
Metyrosine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.00153	CcSEcCtD
Metyrosine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.02e-05	0.00152	CcSEcCtD
Metyrosine—TH—Metabolism—BCHE—peripheral nervous system neoplasm	5e-05	0.00468	CbGpPWpGaD
Metyrosine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.99e-05	0.00151	CcSEcCtD
Metyrosine—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.9e-05	0.00149	CcSEcCtD
Metyrosine—TH—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.77e-05	0.00447	CbGpPWpGaD
Metyrosine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.00142	CcSEcCtD
Metyrosine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.00141	CcSEcCtD
Metyrosine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.53e-05	0.00137	CcSEcCtD
Metyrosine—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.00132	CcSEcCtD
Metyrosine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.00131	CcSEcCtD
Metyrosine—Headache—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.0013	CcSEcCtD
Metyrosine—Nausea—Epirubicin—peripheral nervous system neoplasm	4.05e-05	0.00123	CcSEcCtD
Metyrosine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.00122	CcSEcCtD
Metyrosine—Headache—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.0012	CcSEcCtD
Metyrosine—TH—Metabolism—GNAS—peripheral nervous system neoplasm	3.83e-05	0.0036	CbGpPWpGaD
Metyrosine—TH—Metabolism—ABCB1—peripheral nervous system neoplasm	3.76e-05	0.00353	CbGpPWpGaD
Metyrosine—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.75e-05	0.00114	CcSEcCtD
Metyrosine—TH—Metabolism—AKT1—peripheral nervous system neoplasm	1.03e-05	0.000971	CbGpPWpGaD
